LCZ696, the First-in-Class Angiotensin Receptor Neprilysin Inhibitor, Improves Vascular Reactivity in the Setting of Heart Failure

Authors :: Rishi Trivedi
Traci T. Goodchild
Zhen Li
Daniel Yoo
David J. Lefer
Hiroshi Koiwaya
David J. Polhemus
Source :: Journal of Molecular and Cellular Cardiology. 112:162
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Angiotensin receptor neprilysin inhibitor
Vascular reactivity
Angiotensin II receptor type 1
business.industry
Heart failure
medicine
Pharmacology
Cardiology and Cardiovascular Medicine
medicine.disease
business
Molecular Biology

Full Text Access

Tools